Therapeutic Asset Ratings
191 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Autologous Dendritic Cell-Adenovirus Ccl21 Vaccine
Non-Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(41)
Dendritic Cell Tumor Cell Lysate Vaccine
Glioblastoma
Jonsson Comprehensive Cancer Center
P1
CC
(41)
FAPi-46
Prostate Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(41)
FLUDEOXYGLUCOSE
Brain Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(41)
FLUDEOXYGLUCOSE
Hematopoietic And Lymphoid System Neoplasm
Jonsson Comprehensive Cancer Center
P1
CC
(41)
FLUDEOXYGLUCOSE
Ovarian Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(41)
FLUDEOXYGLUCOSE
Exocrine Pancreatic Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(41)
FLUDEOXYGLUCOSE
Primary Peritoneal Carcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(41)
Ligritinib
Pancreatic Adenocarcinoma
Jonsson Comprehensive Cancer Center
P1
CC
(41)
Autologous Dendritic Cell-Adenovirus Ccl21 Vaccine
Lung Cancer
Jonsson Comprehensive Cancer Center
P1
CC
(40)
ETOPOSIDE
Urothelial Carcinoma
Jonsson Comprehensive Cancer Center
P1
C
(39)
FAPi-46
Urothelial Carcinoma
Jonsson Comprehensive Cancer Center
P1
C
(39)
FLUDEOXYGLUCOSE
Colorectal Carcinoma
Jonsson Comprehensive Cancer Center
P1
C
(39)
FLUOXETINE
Colorectal Adenocarcinoma
Jonsson Comprehensive Cancer Center
P1
C
(39)
BO-112
Hepatocellular Carcinoma
Jonsson Comprehensive Cancer Center
Early P1
C
(38)
Eras-801
Glioblastoma
Jonsson Comprehensive Cancer Center
P1
C
(37)
Showing 176 to 191 of 191 assets
Previous
Page 8 of 8
Next
